Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridoxine as Add-on Therapy in OCD
NCT06244121Recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Standard treatment with pyridoxine with Standard treatment with placebo (2 arms). Primary endpoint: Yale-Brown Obsessive Compulsive Scale at 8 weeks. Started Jun 2023; status: recruiting.
02
Drugs
pyridoxine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT06244121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06244121.